Pharmaceutical Technology on MSN
High-dose biologic delivery to become industry standard
As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.
Classically, the study of pharmacokinetics (PK) has centered on hepatic metabolism and renal excretion as the primary ...
Everyday Health on MSN
How the new oral GLP-1 weight loss medications work
Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results